Eocene Ltd. (NasdaqCM: EOCN)
Health Care · Biotechnology · IL
$3.37
-12.24% today · -71.3% 1Y
Eocene Ltd. (NasdaqCM: EOCN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.37M and employs 6 people.
Over the last twelve months the share price has lost 71.3%, trading between 3.27 and 13.20.
Tweenvest scores Eocene Ltd. across four factors: quality 38/100, value 49/100. Its strongest factor is value.
EOCN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.37M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -14.11
- Dividend yield
- —
- Beta (5Y)
- 0.67
- 52-week high
- $13.20
- 52-week low
- $3.27
- Avg volume (3M)
- —
- Shares outstanding
- 1.00M
- Employees
- 6
- Next earnings
- —
About Eocene Ltd.
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
- ISIN
- IL0011313900
- Founded
- 2000
- Listed since
- Mar 12, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tissue Repair LtdASX: TRP | $3.52M | AU$0.08 | +2.50% |
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $3.49M | $0.90 | -0.53% |
| HCW Biologics Inc.NasdaqCM: HCWB | $3.43M | $1.77 | -5.35% |
| BioRestorative Therapies, Inc.NasdaqCM: BRTX | $3.43M | $2.65 | -1.49% |
| VivoSim Labs, Inc.NasdaqCM: VIVS | $3.37M | $0.23 | +0.93% |
| Restart Life Sciences Corp.CNSX: HEAL | $3.36M | CA$0.08 | +7.14% |
| Aptevo Therapeutics Inc.NasdaqCM: APVO | $3.32M | $1.89 | +2.72% |
| Chosa Oncology ABNGM: CHOSA | $3.31M | Skr— | — |
Figures last refreshed Sep 20, 2026.